Analyst Ratings for Sage Therapeutics (SAGE)
SAGE Rating Summary
SAGE Price Target Summary
- Highest: $61.00 (JPMorgan)
- Lowest: $20.00 (Morgan Stanley)
- Average: $28.29
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$28.29 (+46.9%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
Rating Score: 2.5 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
8/8/2023 | Goldman Sachs | Salveen Richter | Downgrade | Neutral (Buy) |
22.00 (N/A) |
16.75 (19.26) |
14.99% | Details |
8/8/2023 | Needham & Company | Ami Fadia | Downgrade | Hold (Buy) |
N/A (N/A) |
16.75 (19.26) |
14.99% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |